|
SLC17A5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.520390E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.644900E-04 |
| Normal-vs-Stage2 |
9.688000E-02 |
| Normal-vs-Stage3 |
9.347200E-01 |
| Normal-vs-Stage4 |
4.468000E-01 |
| Stage1-vs-Stage2 |
4.008200E-01 |
| Stage1-vs-Stage3 |
8.443200E-03 |
| Stage1-vs-Stage4 |
2.629600E-01 |
| Stage2-vs-Stage3 |
1.788220E-01 |
| Stage2-vs-Stage4 |
6.187800E-01 |
| Stage3-vs-Stage4 |
5.653200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.460500E-03 |
| Normal-vs-AfricanAmerican |
2.203400E-01 |
| Normal-vs-Asian |
7.131200E-01 |
| Caucasian-vs-AfricanAmerican |
2.485800E-01 |
| Caucasian-vs-Asian |
6.620600E-01 |
| AfricanAmerican-vs-Asian |
9.373800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.922700E-03 |
| Normal-vs-Female |
1.394820E-01 |
| Male-vs-Female |
1.632220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.868210E-01 |
| Normal-vs-Extreme_Weight |
3.40720000002737E-06 |
| Normal-vs-Obese |
8.135600E-02 |
| Normal-vs-Extreme_Obese |
9.636400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.425450E-01 |
| Normal_Weight-vs-Obese |
9.604200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.280200E-01 |
| Extreme_Weight-vs-Obese |
9.037100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.118600E-01 |
| Obese-vs-Extreme_Obese |
8.161500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.156600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.647650E-02 |
| Normal-vs-Age(61-80Yrs) |
4.275800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.160800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.456800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.655200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.527800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.732400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.400200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.273800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.20999999997373E-06 |
| Normal-VS-Type2 PRCC |
6.455800E-01 |
| Normal-VS-KIRP CIMP |
4.031200E-01 |
| Normal-VS-Unclassified PRCC |
5.559700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.40990000000197E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.451700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.617600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.702200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.961600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.565200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.695900E-02 |
| Normal-vs-N1 |
6.441400E-01 |
| Normal-vs-N2 |
5.435900E-02 |
| N0-vs-N1 |
3.623600E-02 |
| N0-vs-N2 |
5.423600E-01 |
| N1-vs-N2 |
6.195000E-03 |
|
|
